Form 4: Baxter International EVP Alok Sonig Reports Equity Grant and Resulting Change in Beneficial Ownership

Alok Sonig, EVP and Group President, Pharma at Baxter International, reported the acquisition of restricted stock units (RSUs) and a resulting adjustment in their beneficial ownership of company stock on March 6, 2024.

Summary

• On March 6, 2024, Alok Sonig, an EVP at Baxter International, reported a transaction involving the company's common stock.
• The transaction involved the acquisition of 83,353 shares of common stock at $0 price.
• This acquisition was due to an annual equity grant consisting solely of restricted stock units (RSUs).
• These RSUs vest in three equal annual installments starting on March 6, 2025.
• Following the transaction, Sonig directly owns 113,454 shares of Baxter International.
• Sonig has granted power of attorney to David S. Rosenbloom, Ellen K. Bradford, and Kimberly Olson to execute and file SEC forms on their behalf.

Sentiment

Score: 6

Explanation: The document reflects a routine executive compensation transaction. It's neither overwhelmingly positive nor negative, but indicates continued investment in the company by a key executive.

Positives

• The equity grant to a top executive signals confidence in the company's future performance.

Future Outlook

The RSUs are scheduled to vest in three equal annual installments beginning on March 6, 2025, subject to continued employment and the terms of the Baxter International Inc. 2021 Incentive Plan.

Industry Context

Equity grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Equity grants are a standard component of executive compensation packages in large, publicly traded companies like Baxter International.
• Companies like Johnson & Johnson, Pfizer, and Abbott Laboratories also utilize RSUs and stock options as part of their executive compensation plans.
• The vesting schedule of three years is also typical for RSU grants.

Stakeholder Impact

• The equity grant aligns the executive's interests with those of shareholders, potentially driving long-term value creation.

Key Dates